Yolanda Taylor

Transcelerate Biopharma Program Lead @Boehringer Ingelheim

Indianapolis, IN, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Feb 2025 — Present

Transcelerate Biopharma Program Lead @Boehringer Ingelheim

View department →

US

Serving as the TCB program leader for Boehringer-Ingelheim in conjunction with current leadership role. Responsible for integration of TCB intiatives, driving TVB strategy, and serving as interface between TVB and Boehringer

EDUCATION

1987 — 1991

The University of Kansas

Bachelor's degree, Biology, General

1991 — 1995

The University of Kansas

Doctor of Pharmacy (Pharm.D.), Pharmacy

SKILLS

Risk AssessmentFmeaClinical TrialsProject ManagementBiotechnologyPublications Strategy LeadershipCross-Functional Team LeadershipTherapeutic AreasRoot Cause AnalysisMedical Affairs LeadershipSix SigmaEndocrinologyStrategic PlanningDrug DevelopmentGcpOncologyIch-GcpMedical WritingPharmaceutical IndustryBusiness Process ImprovementSopClinical DevelopmentClinical ResearchCapaRegulatory SubmissionsStandard Operating Procedure (Sop)Medical Quality Management

ABOUT YOLANDA TAYLOR

Dynamic and strategic Sr Leader who has successfully led large cross-functional teams within the pharmaceutical/biotechnology industry. Demonstrated strengths in Medical Affairs leadership, Medical Writing leadership, Oncology, Clinical Development leadership, Six Sigma, Budget Management, and Cross functional drug development strategy. Leader of Good Clinical Practice (GCP) with a focus on patient centricity in Clinical Research. Strong leader of research professionals within multiple drug development disciplines. Educated with a Doctor of Pharmacy (Pharm.D.) from the University of Kansas.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Yolanda Taylor — Transcelerate Biopharma Program Lead at Boehringer Ingelheim in Indianapolis, IN, US | Unifers